EUVIMEDExplore EUVIMED
Crossref

Unique Device Identifier Deployment: Role and Challenges in Traceability and Expedited Device Approvals Across the European Union and United States

Divyasree Baraneetharan, Shivanand K Mutta

EJPPS - European Journal of Parenteral and Pharmaceutical Sciences · 2026-07-02

DOI: 10.37521/ejpps31209 ↗

At a glance

Journal article in EJPPS - European Journal of Parenteral and Pharmaceutical Sciences, published online on 2026-07-02. Written by Divyasree Baraneetharan and 1 co-authors. 40 references.

AbstractBibliographic detailsCiteRelated studies

Abstract (original language)

Unique Device Identifier (UDI) system has become an important regulation instrument in enhancing medical devices traceability and post-market supervision in the European Union (EU) and the United States (US). UDI systems enhance patient safety, efficiency of recall, and facilitate creation of real-world evidence to make regulatory decisions by allocating standardized identifiers and connecting these identifiers with centralized databases on devices. This review will summarize regulatory requirements and implementation experience of UDI under the European medical device regulations and the United States Food and Drug Administration UDI rule, and highlight the supply-chain transparency, lifecycle monitoring as well as a possible way of enabling expedited approvals of devices. Although these regulations have been made, there exist numerous obstacles which prevent an effective implementation, such as old information technology infrastructure, poor data quality, lack of complete integration with clinical and administrative systems, inconsistent adoption of standards, and delays in the full operationalization of databases. These issues limit the achievement of UDI advantages of surveillance and regulatory dependence. The review presents feasible measures in implementing stage-by-stage, better governance, and coordination of cross-stakeholders to effectively utilize UDI in traceability, post-market surveillance, and evidence-based regulatory directions in interjurisdiction. Keywords: Medical Device Traceability, Post-market Surveillance, Real-world Evidence, Regulatory Science, Unique Device Identifier.

Cite

APA

Baraneetharan, D., & Mutta, S. K. (2026). Unique Device Identifier Deployment: Role and Challenges in Traceability and Expedited Device Approvals Across the European Union and United States. EJPPS - European Journal of Parenteral and Pharmaceutical Sciences. https://doi.org/10.37521/ejpps31209

Vancouver

Baraneetharan D, Mutta SK. Unique Device Identifier Deployment: Role and Challenges in Traceability and Expedited Device Approvals Across the European Union and United States. EJPPS - European Journal of Parenteral and Pharmaceutical Sciences. 2026. doi:10.37521/ejpps31209

BibTeX
@article{Baraneetharan2026,
  author = {Baraneetharan, Divyasree and Mutta, Shivanand K},
  title = {Unique Device Identifier Deployment: Role and Challenges in Traceability and Expedited Device Approvals Across the European Union and United States},
  journal = {EJPPS - European Journal of Parenteral and Pharmaceutical Sciences},
  year = {2026},
  doi = {10.37521/ejpps31209}
}
Start for free →